Decreased levels of serum brain-derived neurotrophic factor in male pediatric patients with depression

Open Clinical Chemistry Journal

Volumn 4, Issue 1, 2011, Pages 28-33

  Sasaki, Tsuyoshi ^a   Niitsu, Tomihisa ^a   Hashimoto, Tasuku ^a   Kanahara, Nobuhisa ^a   Shiina, Akihiro ^a   Hasegawa, Tadashi ^a   Kimura, Hiroshi ^a   Ishikawa, Maki ^b   Tone, Junko ^a   Yamauchi, Atsushi ^a   Hosoda, Yutaka ^a   Kunou, Masaru ^c   Takahashi, Junpei ^c   Ishima, Tamaki ^d   Fujita, Yuko ^d   Nakazato, Michiko ^a   Hashimoto, Kenji ^d   Iyo, Masaomi ^a,d  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Chiba Psychiatric Medical Center   (Japan)

^c CHIBA AOBA MUNICIPAL HOSPITAL   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Biomarker; Brain derived neurotrophic factor (BDNF); Pediatric depression; Serum

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADOLESCENT; ARTICLE; CHILD; CHILDREN DEPRESSION RATING SCALE REVISED; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATHOPHYSIOLOGY; PATIENT; PEDIATRIC PATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SCORING SYSTEM;

EID: 80053495730     PISSN: None     EISSN: 18742416     Source Type: Journal    
DOI: 10.2174/1874241601104010028     Document Type: Article

References (38)

1. Kessler, R.C.; McGonagle, K.A.; Zhao, S.; Nelson, C.B.; Hughes, M.; Eshleman, S.; Wittchen, H.U.; Kendler, K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry, 1994, 5, 8-19.
2. Hirschfeld, R.M.; Weissman, M.M. Risk factors for major depression and bipolar disorder. In: Davis, K.L.; Charney, D.; Coyle, J.T.; Nemeroff, C.; Eds. Neuropsychopharmacology-The Fifth Generation of Progress. Lippincott Williams & Wilkins, Philadelphia, USA 2002; 1017-25.
3. Belmaker, R.H.; Agam, G. Major depressive disorder. N. Eng. J. Med., 2008, 358, 55-68.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Press: Washington, DC, 1994.
5. Brent, D.A.; Maalouf, F.T. Pediatric depression: is there evidence to improve evidence-based treatments? J. Child. Psychol. Psychiatry, 2009, 50, 143-152.
6. Fleming, J.E.; Offord, D.R. Epidemiology of childhood depressive disorders: a critical review. J. Am. Acad. Child. Adolesc. Psychiatry, 1990, 29(4), 571-80.
7. Kandel, D.B.; Davies, M. Adult sequelae of adolescent depressive symptoms. Arch. Gen. Psychiatry, 1986, 43(3), 255-262.
8. Kovacs, M.; Feinberg, T.L.; Crouse-Novak, M.A.; Paulauskas, S.L.; Finkelstein, R. Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery. Arch. Gen. Psychiatry, 1984, 41(3), 229-237.
9. Pfeffer, C.R.; Klerman, G.L.; Hurt, S.W.; Lesser, M.; Peskin, J.R.; Siefker, C.A. Suicidal children grow up: demographic and clinical risk factors for adolescent suicide attempts. J. Am. Acad. Child. Adolesc. Psychiatry, 1991; 30(4), 609-616.
10. Birmaher, B.; Ryan, N.D.; Williamson, D.E.; Brent, D.A.; Kaufman, J. Childhood and adolescent depression: a review of the past 10 years. Part II. J. Am. Acad. Child. Adolesc. Psychiatry, 1996, 35(12), 1575-1583.
11. Birmaher, B.; Brent, D.; AACAP Work Group on Quality Issues; Bernet, W.; Bukstein, O.; Walter, H.; Benson, R.S.; Chrisman, A.; Farchione, T.; Greenhill, L.; Hamilton, J.; Keable, H.; Kinlan, J.; Schoettle, U.; Stock, S.; Ptakowski, K.K.; Medicus, J. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J. Am. Acad. Child. Adolesc. Psychiatry, 2007, 46(11), 1503-1526.
12. Brent, D.A. Correlates of the medical lethality of suicide attempts in children and adolescents. J. Am. Acad. Child. Adolesc. Psychiatry, 1987, 26(1), 87-91.
13. Maalouf, F.T.; Brent, D.A. Pharmacotherapy and psychotherapy of pediatric depression. Expert Opin. Pharmacother., 2010, 11, 2129-2140.
14. Ising, M.; Horsmann, S.; Kloiber, S.; Lucae, S.; Binder, E.B.; Kern, N.; Künzel, H.E.; Pfennig, A.; Uhr, M.; Holsboer, F. Combined dexamethasone/corticotrophin releasing hormone test predicts treatment response in major depression-a potential biomarker. Biol. Psychiatry, 2007, 62, 47-54.
15. Miller, A.H.; Maletic, V.; Raison, C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry, 2009, 65, 732-741.
16. Lakhan, S.E.; Vieira, K.; Hamlat, E. Biomarkers in psychiatry: Drawbacks and potential for misuse. Int. Arch. Med., 2010, 3, 1.
17. Domenici, E.; Wille, D.R.; Tozzi, F.; Prokopenko, I.; Miller, S.; McKeown, A.; Brittain, C.; Rujescu, D.; Giegling, I.; Turck, C.W.; Holsboer, F.; Bullmore, E.T.; Middleton, L.; Merlo-Pich, E.; Alexander, R.C.; Muglia, P. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS ONE 2010, 5, e9166.
18. Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin. Neurosci., 2010, 64(4), 341-357.
19. Duman, R.S.; Heninger, G.R.; Nestler, E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry., 1997, 54(7), 597-606.
20. Altar, C.A. Neurotrophins and depression. Trends Pharmacol. Sci., 1999, 20(2), 59-61.
21. Nestler, E.J.; Gould, E.; Manji, H.K.; et al. Preclinical models: status of basic research in depression. Biol. Psychiatry, 2002, 52, 503-528.
22. Hashimoto, K.; Shimizu, E.; Iyo, M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res. Brain Res. Rev., 2004, 45(2), 104-114.
23. Martinowich, K.; Manji, H.; Lu, B. New insights into BDNF function in depression and anxiety. Nat. Neurosci., 2007, 10(9), 1089-1093.
24. Shimizu, E.; Hashimoto, K.; Okamura, N.; Koike, K.; Komatsu, N.; Kumakiri, C.; Nakazato, M.; Watanabe, H.; Shinoda, N.; Okada, S.; Iyo, M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry, 2003, 54(1), 70-75.
25. Nakazato, M.; Hashimoto, K.; Shimizu, E.; Kumakiri, C.; Koizumi, H.; Okamura, N.; Mitsumori, M.; Komatsu, N.; Iyo, M. Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol. Psychiatry., 2003, 54(4), 485-490.
26. Sen, S.; Duman, R.; Sanacora, G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: metaanalyses and implications. Biol. Psychiatry, 2008, 64(6), 527-532.
27. Brunoni, A.R.; Lopes, M.; Fregni, F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol., 2008, 11(8), 1169-1180.
28. Bocchio-Chiavetto, L.; Bagnardi, V.; Zanardini, R.; Molteni, R.; Nielsen, M.G.; Placentino, A.; Giovannini, C.; Rillosi, L.; Ventriglia, M.; Riva, M.A.; Gennarelli, M. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J. Biol. Psychiatry, 2010, 11(6), 763-773.
29. Molendijk, M.L.; Bus, B.A.; Spinhoven, P.; Penninx, B.W.; Kenis, G.; Prickaerts, J.; Voshaar, R.O.; Elzinga, B.M. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol. Psychiatry, 2010.
30. Lewinsohn, P.M.; Rohde, P.; Seeley, J.R. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin. Psychol. Rev., 1998, 18(7), 765-794.
31. Hänninen V, Aro H. Sex differences in coping and depression among young adults. Soc. Sci. Med., 1996, 43(10), 1453-1460.
32. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines.
33. Poznanski, E.O.; Grossman, J.A.; Buchsbaum, Y.; Banegas, M.; Freeman, L.; Gibbons, R. Preliminary studies of the reliability and validity of the children's depression rating scale. J. Am. Acad. Child. Psychiatry, 1984, 23, 191-197.
34. Sheehan, D.V.; Sheehan, K.H.; Shytle, R.D.; Janavs, J.; Bannon, Y.; Rogers, J.E.; Milo, K.M.; Stock, S.L.; Wilkinson, B. Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). J. Clin. Psychiatry, 2010, 71(3), 313-326.
35. Pandey, G.N.; Dwivedi, Y.; Rizavi, H.S.; Ren, X.; Zhang, H.; Pavuluri, M.N. Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2010, 34(4), 645-651.
36. Park, R.J.; Goodyer, I.M. Clinical guidelines for depressive disorders in childhood and adolescence. Eur. Child. Adolesc. Psychiatry, 2000, 9(3), 147-161.
37. Lin, P.Y. State-dependent decrease in levels of brainderived neurotrophic factor in bipolar disorder: a metaanalytic study. Neurosci. Lett., 2009, 466, 139-143.
38. Jonsson, U.; Bohman, H.; von Knorring, L.; Olsson, G.; Paaren, A.; von Knorring, A.L. Mental health outcome of long-term and episodic adolescent depression: 15-year follow-up of a community sample. J. Affect. Disord., 2011, 130(3), 395-404.